Trauma Fixation Devices Market Trends

Global Trauma Fixation Devices Market Overview

The Trauma Fixation Devices Market Size was valued at USD 8.5 Billion in 2022 and is projected to grow from USD 8.8 Billion in 2023 to USD 12.3 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.22% during the forecast period (2023 - 2032). Road traffic accidents and injuries are on the rise, and advancement in trauma fixation technology are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Trauma Fixation Devices Market Trends

• Demand for trauma fixation devices in hospitals is driving the market growth

A significant global cause of death is traffic accidents. Trauma fixation devices are necessary for the recovery of injuries sustained in auto accidents. Approximately 3,700 people worldwide lose their lives every day in bus, motorcycle, bicycle, truck, or pedestrian accidents, according to the Centers for Disease Control and Prevention. More than half of those fatalities involve cyclists, motorcyclists, and pedestrians. Additionally, the need for trauma fixation devices is increasing due to technologically advanced products like bioresorbable implants and nano-coated goods. Depuy Synthes, a division of Johnson & Johnson, introduced Dynacord Suture in numerous European countries in June 2020. Among other procedures, the suture is used for soft tissue approximation and rotator cuff repairs.

Degenerative bone conditions include osteoporosis, Paget's disease, and osteoarthritis deteriorate bones and result in painful, stiff joints. Adults over the age of 40 are more likely to develop osteoarthritis, and the risk of the condition increases with age. In the world, there were 900 million persons aged 60 or over (12% of the total population), and by 2050, that figure is projected to increase to 2 billion (22% of the entire population).

Additionally, on the rise are tumor resections, plate and screw damage, intramedullary nail damage, humeral and femoral nail fractures, hip fractures, and fractures of the tibia, foot, and ankle. Additionally, the rising demand for goods including peek implants, paek polymers (used in cases of facial injuries), bioabsorbable fixation devices, and temporary Fixation devices is promoting market expansion. Thus, driving the Trauma Fixation Devices market revenue.

Trauma Fixation Devices Market Segment Insights

Trauma Fixation Devices Product Insights

The Trauma Fixation Devices Market segmentation, based on product includes external fixator devices and internal fixator devices. Based on the product, the market for external fixator devices held the highest share in 2022 as a result of a shift in key industry participants' focus to various closure devices. Circular external fixation is a safe and effective treatment for periprosthetic fractures around the knee in elderly patients, per research published in BMC Musculoskeletal Disorders 2020. The key market players are also providing a variety of cutting-edge products, which is promoting market growth.

Trauma Fixation Devices Surgical Site Insights

The Trauma Fixation Devices Market segmentation, based on surgical site, includes upper extremities and lower extremities. The lower extremities held the largest industry share in 2022. The foot and ankle, thigh, hip and pelvis, lower leg, and knee are all parts of the lower extremities. The growth is brought on by an increase in the number of people experiencing osteoporosis, traumatic accidents, and bone-related injuries. The global market for lower extremities trauma devices is expected to grow as a result of rising rates of traffic accidents and injuries around the world as well as increased awareness of trauma devices.

Trauma Fixation Devices Material Insights

The Trauma Fixation Devices Market segmentation, based on Material, includes metallic implant, hybrid implant, bio absorbable, carbon fibre, and grafts and orthobiologics. In 2022, the Metallic Implant had the biggest market share because to its various benefits, including biocompatibility, superelasticity, fatigue and kink resistance, etc., its use is expanding globally, supporting the development of the internal trauma fixation device market.

Figure 1: Trauma Fixation Devices Market, by Material, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Trauma Fixation Devices End user Insights

The Trauma Fixation Devices Market segmentation, based on End User, includes hospitals, orthopedic surgical centers, clinics, and others. Due to an increase in the number of accidental cases admitted into hospitals, the hospitals segment is anticipated to dominate the market in 2022.

Trauma Fixation Devices Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. Due to its supportive healthcare reimbursement policies, higher accident rates, and convenient access to contemporary technologies, North America Trauma Fixation Devices market held the top spot in the regional category in 2022 (45.80%). The CDC reports that unintentional injuries resulted in 169,936 fatalities in the US in May 2020, as well as 39.5 million doctor visits and 29.4 million visits to emergency rooms. The industry's expansion is also greatly aided by large competitors in the region. Moreover, the U.S. Trauma Fixation Devices market held the largest market share, and the Canada Trauma Fixation Devices market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: TRAUMA FIXATION DEVICES MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

The key reasons influencing the future growth of the European trauma fixation devices market are the rise in prevalence and incidence of bone fractures, a growing older population, and the wide range of solutions provided by industry participants. Due to population aging, hip fractures and other bone conditions like osteoporosis are becoming more common. Additionally, the rise of road accidents increases demand for these devices. Further, the German Trauma Fixation Devices market held the largest market share, and the UK Trauma Fixation Devices market was the fastest growing market in the European region.

Throughout the projection period, the Asia-Pacific Trauma Fixation Devices market is anticipated to grow quickly. Additionally, the market is anticipated to be driven by growing healthcare costs, improving economic conditions, higher consumer awareness of better internal trauma fixation devices, and technological advancements during the course of the forecasted period. Moreover, China’s Trauma Fixation Devices market held the largest market share, and the Indian Trauma Fixation Devices market was the fastest growing market in the Asia-Pacific region.

Trauma Fixation Devices Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Trauma Fixation Devices market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Trauma Fixation Devices industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Trauma Fixation Devices industry to benefit clients and increase the market sector. In recent years, the Trauma Fixation Devices industry has offered some of the most significant advantages to medicine. Major players in the Trauma Fixation Devices market, including Thermo Fisher Scientific, Inc., R&D Systems, Abcam plc, Merck KGaA, Proteintech Group, Inc., Janssen-Cilag Pty Ltd., Aviva Systems Biology, Bio-Techne Corporation, Elpiscience BioPharma, Eli Lilly and co., GigaGen Inc., are attempting to increase market demand by investing in research and development operations.

A Johnson & Johnson subsidiary called DePuy Synthes Inc (DePuy Synthes) manufactures medical devices for orthopedic operations. The business provides orthopedic treatments and products in the fields of cranio-maxillofacial, sports medicine, trauma, spine, joint reconstruction, power tools, and biomaterials. One of its main offerings is the Attune revision knee system, which gives surgeons control over both primary and revision knee operations. The business sells its goods to a variety of customers, including doctors, hospitals, surgeons, and carers. The business distributes goods in both domestic and foreign markets. In the US, DePuy Synthes has its headquarters in Warsaw, Indiana. A set of implants for replacing the radial head was released by DePuy Syntheses in December 2020. Patients with destabilized radial head fractures are intended users of the system.

A manufacturer of a variety of orthopedic, medical, surgical, neurotechnology, and spine equipment as well as related services, Stryker Corp (Stryker) is a leader in the field of medical technology. The company's main goods include orthopedic implants, surgical tools and navigation systems, patient handling tools, disposable intensive care items, and endoscopic and communication systems. Additionally, it supplies medical devices for use in a range of ailments as well as neurosurgical equipment, neurovascular, and spinal devices. Doctors, hospitals, and other healthcare facilities can purchase products from Stryker. In the Americas, Europe, Asia-Pacific, the Middle East, and Africa, the corporation distributes its products through subsidiaries, branches, independent dealers, and distributors. The US city of Kalamazoo, Michigan, is home to Stryker's headquarters. The T2 ICF Intramedullary nailing device, which offers a treatment for patients with severe foot problems like Charcot foot, was introduced by Stryker Corporation in September 2020. Diabetes patients experience reduced bone quality because of this.

Key Companies in the Trauma Fixation Devices market include

• Thermo Fisher Scientific, Inc.


• R&D Systems


• Abcam plc


• Merck KGaA


• Proteintech Group, Inc.


• Janssen-Cilag Pty Ltd.


• Aviva Systems Biology


• Bio-Techne Corporation


• Elpiscience BioPharma


• Eli Lilly and co.


• GigaGen Inc.

Trauma Fixation Devices Industry Developments

July 2020 Orthofix's 'JuniOrtho plating system' has acquired approval from the US Food and Drug Administration and the CE Mark. The lower extremities of juvenile patients who have extensive deformities and injuries can be repaired using this device.

September 2019 At the Orthopedic Trauma Association, Smith + Nephew presented the INTERTAN Product Assurance (IPA) program.

Trauma Fixation Devices Market Segmentation

Trauma Fixation Devices Product Outlook

• External Fixator Devices


• Internal Fixator Devices

Trauma Fixation Devices Surgical Site Outlook

• Upper Extremities


• Lower Extremities

Trauma Fixation Devices Material Outlook

• Metallic Implant


• Hybrid Implant


• Bio Absorbable


• Carbon Fibre


• Grafts and Orthobiologics

Trauma Fixation Devices End User Outlook

• Hospitals


• Orthopedic surgical centers


• Clinics


• Others

Trauma Fixation Devices Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America